BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28210085)

  • 21. Evaluation of dynamic effects of therapy-induced changes in microcirculation after percutaneous treatment of vascular malformations using contrast-enhanced ultrasound (CEUS) and time intensity curve (TIC) analyses.
    Wiesinger I; Jung W; Zausig N; Wohlgemuth WA; Pregler B; Wiggermann P; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2018; 69(1-2):45-57. PubMed ID: 29630543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound.
    Zhou JH; Li AH; Cao LH; Jiang HH; Liu LZ; Pei XQ; Han F
    Br J Radiol; 2008 Feb; 81(962):113-9. PubMed ID: 18070827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
    Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
    Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver involvement in hereditary hemorrhagic telangiectasia.
    Buscarini E; Gandolfi S; Alicante S; Londoni C; Manfredi G
    Abdom Radiol (NY); 2018 Aug; 43(8):1920-1930. PubMed ID: 29987403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic involvement of hereditary hemorrhagic telangiectasia: evaluation with ultrasound.
    McCann TE; Scoutt LM; Gunabushanam G
    Ultrasound Q; 2014 Sep; 30(3):221-4. PubMed ID: 25148498
    [No Abstract]   [Full Text] [Related]  

  • 26. Hereditary hemorrhagic telangiectasia: how to efficiently detect hepatic abnormalities using ultrasonography.
    Naganuma H; Ishida H; Kuroda H; Suzuki Y; Ogawa M
    J Med Ultrason (2001); 2020 Jul; 47(3):421-433. PubMed ID: 32390074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of pulmonary arteriovenous fistula associated with multiple hepatic arterioportal shunts].
    Shukuya T; Atsuta R; Morio Y; Sato K; Suzuki T; Seyama K; Takahashi K
    Nihon Kokyuki Gakkai Zasshi; 2007 Sep; 45(9):715-9. PubMed ID: 17929475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portal shunt scintigraphy (PSS) in the evaluation of patients suspected of hereditary hemorrhagic telangiectasia.
    Nozawa A; Miller FJ; Rivandi AH; Hoh CK
    Clin Nucl Med; 2013 Sep; 38(9):741-3. PubMed ID: 23797221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
    Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
    Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia.
    Buscarini E; Danesino C; Plauchu H; de Fazio C; Olivieri C; Brambilla G; Menozzi F; Reduzzi L; Blotta P; Gazzaniga P; Pagella F; Grosso M; Pongiglione G; Cappiello J; Zambelli A
    Ultrasound Med Biol; 2004 Sep; 30(9):1089-97. PubMed ID: 15550313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs.
    Memeo M; Stabile Ianora AA; Scardapane A; Suppressa P; Cirulli A; Sabbà C; Rotondo A; Angelelli G
    Radiol Med; 2005; 109(1-2):125-38. PubMed ID: 15729193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral perfusion in perinatal hypoxia and resuscitation assessed by transcranial contrast-enhanced ultrasound and 3 T MRI in newborn pigs.
    de Lange C; Brabrand K; Emblem KE; Bjornerud A; Løberg EM; Saugstad OD; Munkeby BH
    Invest Radiol; 2011 Nov; 46(11):686-96. PubMed ID: 21730873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of haemorrhagic hereditary telangiectasia in adult patients.
    Riera-Mestre A; Ribas J; Castellote J
    Med Clin (Barc); 2019 Apr; 152(7):274-280. PubMed ID: 30502301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfusion quantification of vascular malformations using contrast-enhanced ultrasound (CEUS) with time intensity curve analysis before and after treatment: First results.
    Wiesinger I; Schreml S; Wohlgemuth WA; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2015 Sep; 62(4):283-90. PubMed ID: 26444594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Color Doppler sonography of vascular malformations of the liver.
    Shapiro RS; Winsberg F; Stancato-Pasik A; Sterling KM
    J Ultrasound Med; 1993 Jun; 12(6):343-8. PubMed ID: 8515532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage.
    Hagiwara S; Takase T; Oda I; Komeda Y; Nishida N; Yoshida A; Yamamoto T; Matsubara T; Kudo M
    Clin J Gastroenterol; 2024 Jun; 17(3):477-483. PubMed ID: 38436842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.
    Buscarini E; Leandro G; Conte D; Danesino C; Daina E; Manfredi G; Lupinacci G; Brambilla G; Menozzi F; De Grazia F; Gazzaniga P; Inama G; Bonardi R; Blotta P; Forner P; Olivieri C; Perna A; Grosso M; Pongiglione G; Boccardi E; Pagella F; Rossi G; Zambelli A
    Dig Dis Sci; 2011 Jul; 56(7):2166-78. PubMed ID: 21290179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion.
    Haimerl M; Brünn K; Poelsterl S; Beyer LP; Wiesinger I; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2017; 67(3-4):373-382. PubMed ID: 28885204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous delayed enhancement of hepatic parenchyma after intravenous infusion of sonographic contrast agent: a new hypothesis.
    Caruso G; Martegani A; Aiani L; Borghi C; Verderame F; Campisi A; Salvaggio G; Lagalla R; Cardinale AE
    Radiol Med; 2007 Feb; 112(1):56-63. PubMed ID: 17310291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.